Efficacy of group biofeedback in patients with residual schizophrenia

XUE Qianqian; CHEN Changhao; LI Fangmei; YU Xiumei; SI Xiaoxiao; YANG Yan

doi:10.7619/jcmp.20231836

Journal of Clinical Medicine in Practice > 2023 > 27(22): 95-99. > DOI: 10.7619/jcmp.20231836

XUE Qianqian, CHEN Changhao, LI Fangmei, YU Xiumei, SI Xiaoxiao, YANG Yan. Efficacy of group biofeedback in patients with residual schizophrenia[J]. Journal of Clinical Medicine in Practice, 2023, 27(22): 95-99. DOI: 10.7619/jcmp.20231836

Citation:

PDF (734 KB)

Efficacy of group biofeedback in patients with residual schizophrenia

1.
Department of Psychiatric Rehabilitation, the Second People's Hospital of Suzhou in Anhui Province, Suzhou, Anhui, 234000
2.
Department of Sleep Disorders, the Second People's Hospital of Suzhou in Anhui Province, Suzhou, Anhui, 234000

More Information

Received Date: June 06, 2023
Revised Date: September 11, 2023
Available Online: December 05, 2023

Graphical Abstract

Abstract

Abstract

Objective
To observe the effect of group biofeedback in patients with residual schizophrenia (RS).
Methods
A total of 127 patients with RS were selected as study objects, and randomly divided into control group (n=63) and observation group (n=64). The control group received routine nursing, and the observation group received group biofeedback based on the control group. The Positive and Negative Symptom Scale (PANSS), Personal and Social Performance Scale (PSP) and Self-awareness Inventory (SAI) Questionnaire (treatment compliance) scores were compared between the two groups.
Results
After 12 weeks of intervention, the score of the positive symptoms, the score of negative symptoms and the total score of PANSS in the observation group were significantly lower than those in the control group (P < 0.05). The number of patients with PSP scores greater than 70 to 100 and greater than 30 to 70 in the observation group was significantly more than those in the control group, and the number of patients with PSP score of 0 to 30 was significantly less than that in the control group (P < 0.05). The SAI score of the observation group after intervention was significantly higher than that before intervention and control group, and the number of completed biofeedback therapy in the observation group was significantly more than that in the control group (P < 0.05).
Conclusion
Group biofeedback can promote symptom relief and improve treatment compliance in patients with RS.
- residual type,
- schizophrenia,
- group biofeedback therapy,
- social function

FullText(HTML)

References (28)

References

[1]	陈云郁, 王国民, 倪燕飞. 奥氮平联合高频重复经颅磁刺激治疗残留型精神分裂症的临床分析[J]. 现代实用医学, 2022, 34(6): 760-762. doi: 10.3969/j.issn.1671-0800.2022.06.023
[2]	REDAELLI S, PORFFY L, OLOYEDE E, et al. Vortioxetine as adjunctive therapy in the treatment of schizophrenia[J]. Ther Adv Psychopharmacol, 2022, 12: 20451253221110014.
[3]	CAI Y Y, GONG W J, HE W J, et al. Residual effect of texting to promote medication adherence for villagers with schizophrenia in China: 18-month follow-up survey after the randomized controlled trial discontinuation[J]. JMIR Mhealth Uhealth, 2022, 10(4): e33628. doi: 10.2196/33628
[4]	李丹, 徐彩娟, 周燕玲, 等. 残留型精神分裂症患者的社会功能与精神病性症状及认知功能的相关性[J]. 中国临床心理学杂志, 2018, 26(2): 333-335, 346. doi: 10.16128/j.cnki.1005-3611.2018.02.026
[5]	何彩娣, 郎伯旭, 金灵青, 等. 头针联合脑电生物反馈疗法治疗儿童注意缺陷多动障碍: 随机对照研究[J]. 中国针灸, 2014, 34(12): 1179-1183. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGZE201412015.htm
[6]	林晓玲, 宋鲁平. 脑电生物反馈疗法在焦虑障碍中的应用[J]. 中华物理医学与康复杂志, 2015, 37(2): 158-160. doi: 10.3760/cma.j.issn.0254-1424.2015.02.022
[7]	刘敏科, 张静霞, 张兰, 等. 脑电生物反馈疗法联合米氮平对老年抑郁症患者临床治疗效果观察[J]. 基因组学与应用生物学, 2018, 37(1): 102-108. https://www.cnki.com.cn/Article/CJFDTOTAL-GXNB201801022.htm
[8]	孔燕, 胡建军. 《自闭症儿童舞蹈治疗康复手册》出版: 脑电生物反馈结合舞动疗法对自闭症儿童的训练效果研究[J]. 介入放射学杂志, 2022, 31(6): 637-637. https://www.cnki.com.cn/Article/CJFDTOTAL-JRFS202206029.htm
[9]	李水英, 周茜, 赖华, 等. 团体社交技能训练对精神分裂症患者精神症状、精神残疾及家庭关系的影响[J]. 中国实用护理杂志, 2014, 30(18): 7-11.
[10]	范肖冬等译. ICD-10精神与行为障碍分类-临床描述与诊断要点[M]. 北京: 人民卫生出版社, 1993: 26-30.
[11]	VOINESKOS A N, FOUSSIAS G, LERCH J, et al. Neuroimaging evidence for the deficit subtype of schizophrenia[J]. JAMA Psychiatry, 2013, 70(5): 472-480. doi: 10.1001/jamapsychiatry.2013.786
[12]	TIAN S. The reliability and validity of Chinese version of Personal and Social Performance Scale (PSP) in patients with major depressive disorder(MDD)[J]. Chinese Mental Health Journal, 2010, 24(7): 481-485.
[13]	郑英君, 吴超, 宁玉萍, 等. 用药态度对精神分裂症患者治疗依从性和症状影响的1年随访研究[J]. 中国神经精神疾病杂志, 2017, 43(7): 385-390. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSJJ201707001.htm
[14]	俞丹, 刘茗, 方晓明, 等. 反馈式呼吸电刺激训练对中重度稳定期慢性阻塞性肺疾病患者康复的影响[J]. 实用临床医药杂志, 2022, 26(21): 8-13. doi: 10.7619/jcmp.20222415
[15]	吴晓敏, 陆如平, 马爱兰, 等. 认知行为干预对精神分裂症残留型患者社会功能的影响[J]. 广西医学, 2018, 40(17): 2032-2034. https://www.cnki.com.cn/Article/CJFDTOTAL-GYYX201817035.htm
[16]	闫庆红, 赵淑婉, 刘晓帆, 等. 精神分裂症高危人群脑白质遗传影像学标志物研究进展[J]. 空军军医大学学报, 2023, 44(5): 467-470. https://www.cnki.com.cn/Article/CJFDTOTAL-DSJY202305017.htm
[17]	史翠路, 孙继北, 张春友. 托吡酯联合富马酸喹硫平对精神分裂症患者激越行为及糖脂代谢的影响[J]. 中国临床医生杂志, 2023, 51(3): 304-307. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLYS202303014.htm
[18]	辛伟, 张瑶, 余苒, 等. 精神分裂症患者人格测验加工过程的自我偏向效应及视线追踪特征[J]. 空军军医大学学报, 2022, 43(3): 155-159. https://www.cnki.com.cn/Article/CJFDTOTAL-DSJY202203006.htm
[19]	赵荣江, 牛雅娟, 王刚, 等. 有残留症状的抑郁症患者残留症状对社会功能的影响[J]. 精神医学杂志, 2020, 33(5): 326-329. https://www.cnki.com.cn/Article/CJFDTOTAL-SDJB202005002.htm
[20]	王丽, 梁燕, 郝爽. 生物反馈疗法结合单元护理对非体外循环冠脉搭桥术患者心理状态、认知水平及康复的影响[J]. 中华现代护理杂志, 2021(22): 3025-3028.
[21]	ENGELS L F, CAPPELLO L, FISCHER A, et al. Testing silicone digit extensions as a way to suppress natural sensation to evaluate supplementary tactile feedback[J]. PLoS One, 2021, 16(9): e0256753.
[22]	CAPDEVILA L, PARRADO E, RAMOS-CASTRO J, et al. Resonance frequency is not always stable over time and could be related to the inter-beat interval[J]. Sci Rep, 2021, 11: 8400.
[23]	杨慧青, 何超, 沈妙莉, 等. 精神障碍患者代谢综合征的团体治疗效果研究[J]. 实用临床医药杂志, 2021, 25(3): 47-50. doi: 10.7619/jcmp.20201599
[24]	陈静静, 职彦敏, 郭宁宁. 规范化小组认知行为干预对精神分裂症患者积极心理品质及社会功能的影响[J]. 国际护理学杂志, 2020, 39(23): 4347-4350.
[25]	韩伟新. 精神分裂症患者应用计算机认知矫正治疗的改善效果[J]. 实用临床医药杂志, 2022, 26(14): 50-54. doi: 10.7619/jcmp.20220696
[26]	ALATORRE-CRUZ G C, FERNÁNDEZ T, CASTRO-CHAVIRA S A, et al. One-year follow-up of healthy older adults with electroencephalographic risk for neurocognitive disorder after neurofeedback training[J]. J Alzheimers Dis, 2022, 85(4): 1767-1781.
[27]	DUCHARME P, KAHN J, VAUDREUIL C, et al. A "proof of concept" randomized controlled trial of a video game requiring emotional regulation to augment anger control training[J]. Front Psychiatry, 2021, 12: 591906.
[28]	LEITNER M C, GUETLIN D C, HAWELKA S. Salzburg Visual Field Trainer (SVFT): a virtual reality device for (the evaluation of) neuropsychological rehabilitation[J]. PLoS One, 2021, 16(9): 0249762.

Cited By

Cited by

Periodical cited type(10)

1.	蒋星秀. 康柏西普眼内注射治疗中心性浆液性脉络膜视网膜病变的效果. 临床医学研究与实践. 2024(09): 81-84 .
2.	杨晓峰. 全视网膜激光光凝术联合复合式小梁切除术治疗新生血管性青光眼患者的效果. 中国民康医学. 2022(18): 4-7 .
3.	孟伟. 新生血管性青光眼手术方法及效果分析. 中国继续医学教育. 2021(22): 130-133 .
4.	孙志高，张有亭. 玻璃体腔内注射雷珠单抗辅助复合式小梁切除术对伴玻璃体积血的新生血管性青光眼的疗效. 河南医学研究. 2021(31): 5847-5849 .
5.	吴晓玉，李维娜，徐建锋. 改良式引流阀植入联合康柏西普治疗新生血管性青光眼. 国际眼科杂志. 2020(01): 143-146 .
6.	罗正才，杨云. 玻璃体腔注射康柏西普治疗湿性老年性黄斑变性的临床效果. 河南医学研究. 2020(18): 3363-3364 .
7.	朱瑞曦，杨震雷，李鸿有，宋晗. 睫状体冷冻术治疗NVG的效果观察. 中国卫生标准管理. 2020(16): 38-40 .
8.	娄赟，徐璐，董敬民. Ex-PRESS引流钉植入术治疗新生血管性青光眼患者的疗效观察. 微创医学. 2020(06): 759-761 .
9.	余飞. 抗血管内皮生长因子抑制剂在治疗新生血管性青光眼中的应用价值. 当代医药论丛. 2019(08): 106-108 .
10.	陈年均. 康柏西普辅助治疗新生血管性青光眼手术的临床疗效与组织病理学观察研究. 实用心脑肺血管病杂志. 2019(S1): 20-22 .

Other cited types(0)

Get Citation

PDF

XML

Article views (128) PDF downloads (5) Cited by(10)

Turn off MathJax

Article Contents

Abstract

References

Efficacy of group biofeedback in patients with residual schizophrenia

Abstract

References

Cited by

Periodical cited type(10)

Other cited types(0)

Catalog

Export File

Citation

Format

Content